公司概覽
業務類別 Diagnostics & Research
業務概覽 Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
公司地址 77 4th Avenue, Waltham, MA, USA, 02451
電話號碼 +1 781 663-6900
傳真號碼 --
公司網頁 https://www.revvity.com
員工數量 11000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Joel S. Goldberg Senior Vice President, Administration, General Counsel and Secretary 美元 564.62K 24/02/2026
Mr. Tajinder S. Vohra Senior Vice President, Global Operations 美元 489.62K 24/02/2026
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer 美元 1.13M 16/03/2026
Ms. Miriame Victor Senior Vice President and Chief Commercial Officer 美元 503.27K 24/02/2026
Ms. Anita Gonzales Vice President and Chief Accounting Officer -- 24/02/2026
Mr. Maxwell Krakowiak Senior Vice President and Chief Financial Officer 美元 550.58K 24/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Michael A Klobuchar Independent Director 16/03/2026
Dr. Sophie V. Vandebroek, PhD Independent Director 16/03/2026
Dr. Peter Barrett,PhD Independent Director 16/03/2026
Mr. Alexis P. Michas Non-Executive Chairman of the Board 16/03/2026
Dr. Frank R. Witney,, PhD Independent Director 16/03/2026
Ms. Pascale Witz, M. Sc.,M.B.A. Independent Director 16/03/2026
Mr. Michel Pericles Vounatsos Independent Director 16/03/2026
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer 16/03/2026
Mr. Samuel R. Chapin Independent Director 16/03/2026
Dr. Michelle McMurry-Heath, M.D.,PhD Independent Director 16/03/2026
 
所屬ETF (更新日期: 02/05/2026 03:26)
代號 名稱 佔比% 持有日期
TSNFTruth Social American Next Frontiers ETF0.001%29/04/2026
URSPProShares Ultra S&P 500 Equal Weight0.001%28/02/2026
FABFirst Trust Multi Cap Val AlphaDEX® ETF0.001%29/04/2026
PBPInvesco S&P 500 BuyWrite ETF0.001%29/04/2026
TPLETimothy Plan US Large/Mid Cp Cr Enh ETF0.0005%02/10/2025
AVLCAvantis U.S. Large Cap Equity ETF0.0005%29/04/2026
PEXLPacer US Export Leaders ETF0.0004%29/04/2026
STXVStrive 1000 Value ETF0.0004%29/04/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF0.0004%29/04/2026
IALTiShares Systematic Alternatives Actv ETF0.0004%28/04/2026
MDEVFirst Trust Indxx Global Mdcl Dvcs ETF0.0004%29/04/2026
HCMTDirexion HCM Tactical EnhU.S.EqStratETF0.0004%29/04/2026
SPUUDirexion Daily S&P 500® Bull 2X ETF0.0003%29/04/2026
GSPYGotham Enhanced 500 ETF0.0003%29/04/2026
AVSUAvantis Responsible US Equity ETF0.0003%29/04/2026
ANEWProShares MSCI Trnsfmtnl Chngs ETF0.0002%29/04/2026
INROiShares U.S. Industry Rotation Act ETF0.0002%17/04/2026
GOFGuggenheim Strategic Opp Fund0.0002%30/11/2025
AVTMAvantis Total Equity Markets ETF0.0002%29/04/2026
SPXNProShares S&P 500® ex-Financials0.0001%29/04/2026
  1    2    3    4    5    6   7    8    9    10    11    12  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.